Anxiolytic and Hypnotic Drugs Flashcards
Fluoxetine (Proxac)
MOA
SSRI
Duloxetine (Cymbalta)
MOA
SERT & NET
Blocker
How long does it take to see response in SSRI/SERT&NET blockers?
2-4 week delay
Barbiturate Uses
Induction of anestesia
Epilepsy
Tension/Migraine HA
Barbiturate synergism with which Drugs?
EtOH,
BZD’s,
Z drugs
opioids
Barbiturates
MOA
APLs of all GABAa receptors
Increase DURATION of GABAa channel opening
Barbiturates and tolerance
Rapid PK tolerance due to induction of CYP
Slow PD tolerance:change in receptor number and composition
Ultrashort acting barbiturate use
Induction of anesthesia
Terminal anesthesia
Intermediate acting barbiturate use
Single drug lethal injection
Long acting barbiturate use
Anti-convulsant
Long acting barbiturate example
Phenobarbital
Phenobarbital
MOA
Barbiturate:
APL of GABAa
ADRs for Barb»BZD»Zdrug
Sedation Decreased cognition Decreased REM sleep Hangover -Anterograde Amnesia -Tolerance -Dependence -Ataxia -Withdrawal
How are BZDs similar?
Therapeutic use
pharmaco action
ADRs
How do BZDs differ?
- Onset of action
- Maximal efficacy
- Lipid solubility
- Drug interactions
- Duration of action
- Metabolic pathways
- Active Metabolites
BZD MOA
- APL of GABAa receptor
- Binding increases affinity for endogenous GABA increasing FREQUENCY of channel opening
Barbiturates vs BZDs which increases duration vs frequency of channel opening
Barbiturates: Duration
BZDs: Frequency
Do BZDs directly open the chloride channel?
What is the effect of this?
No.
Difficult to produce fatal respiratory depression in normal pt
Which GABAa subunits do BZDs interact with?
Alpha: 1,2,3, or 5
Which GABAa alpha subunit is most widely distributed, most sedating
Alpha 1
Where is alpha 2 subtype localized?
What is the effect?
Limbic system (Hippocampus and Striatum) Anxiolytic
Where are alpha 3 and 5 subtypes located?
What is the effect?
Spinal chord
Muscle relaxant
Which subtype are Z drugs more selective for?
What is the effect?
Alpha 1
Good hypnotic
Poor muscle relaxant
BZD metabolism
CYP3A4 and CYP2C19
-Do not induce CYP
Do BZDs induce PK tolerance?
No. No CYP induction
BZD Withdrawal
Anxiety Psychosis ANS (N&V, CV, Sweating) Panic, Convulsions
Diazepam (Valium)
Uses
Anxiolytic,
Anticonvulsant,
Muscle Relaxant
Preanesthetic med
What is a major source in variability for BZDs with regards to half life and potency?
Metabolites.
All have different half lives and potency
Flumazenil (Romazicon)
MOA
GABAa (BZD site) direct antagonist
Flumazenil (Romazicon)
Use and administration
IV administration for BZD overdose
Is Flumazenil Used for Barbiturate overdose?
No. It has a different binding site
What is a non-barbiturate, non-BZD drug used for anxiolytic/sedation
Buspirone (Buspar)
Buspirone (Buspar)
MOA
5-HT-1a partial agonist (Gi)
Whereis g-HT-1a highly concentrated?
amygdala and limbic regions of the cortex
Bupsirone (Buspar) primary use
GAD
Buspirone (Buspar) compared to BZDs
-Less sedation and other ADRs
Buspirone (Buspar)
Onset
-Onset delayed for 2-4 weeks
Buspirone (Buspar) ADRs
N&V, dizziness, HA
Buspirone (Buspar)
Metabolism
CYP3A4
Why is Buspirone favored over BZDs for pt with a history of drug abuse?
Non-hypnotic
Non-addictive
When to use caution with buspirone
Think Serotonin
MAOIs or SSRIs
-Better to use BZDs
Buspirone is used for GAD, what about acute panic attacks? Why or why not?
Nope.
Onset 2-4 weeks
Treatment of other anxiety disorders
Anti-depressant(s), buspirone, BZDs (for exacerbations)
-Or cominations
Treatment of anxiety related disorders:
Acute panic attacks
Beta-blockers
What regions regulate non-rem sleep?
The Raphe (5HT) and the nucleus of the solitary tract (NTS) [NE; autonomic control]
Which brain region thought to control REM sleep
Cholinergic regions in the forbrain and midbrain
Effect of BZDs on sleep
Decreased: latency to sleep, time until first REM cycle, number of awakenings
Increased time in stage 2 non-rem sleep
BZDs and REM sleep
Decreased total REM, but increased total sleep. REM rebounds in withdrawal
BZDs and sleep ADRs
Long acting - risk for hangover
Rapid onset have increased abuse potential and rebound insomnia
Zdrug MOA
Interact selectively with Alpha 1 GABAa receptors in “sleep centers”
Zdrugs as anxiolytics, anti-convulsants, or muscle relaxants
Don’t do it!
Wrong GABAa subtype
Zdrugs and abuse
Have abuse potential
Tolerance an occur
Not as bad as barbiturates or BZDs
Difference between Zopiclone (Imovane) and Eszopiclone (Lunesta)?
Eszopiclone (Lunesta) is chiral
Zolpidem (Ambien)
t1/2 and use
~2 h
Use only if full night of sleep is possible
Zalepon (Sonata)
t1/2 and use
~1h
Can take later at night or in the middle of the night
Z drug Use
Approved for short-term (2 weeks at a time)
Less tolerance/dependence/withdrawal, but still not perfect
Melatonin
Circadian synthesis, pineal gland
Facilitates sleep induction and maintenance
Ant-oxidant
output decreases with age
Ramelteon (Rozerem)
MOA
MT1/MT2 receptor agonist
Ramelteon (Rozerem)
Indication
Sleep induction
Ramelteon (Rozerem)
REM
No decrease in time spent in REM
MT1/MT2 Receptor description and location
Gi coupled GPCRs. Hi concentrations in pacemaker regions of hypothalamus
Ramelteon (Rozerem)
ADRs
HA, Sedation, fategue, N/V
Ramelteon (Rozerem)
Onset and Metabolism
30 min
Metabolized by CYP1A2 (No induction)
Tasimelteon (Hetlioz)
Use
Non-24 Sleep-Wake Disorder
70% of Blind Pt
Tasimelteon (Hetlioz) Vs Ramelteon (Rozerem)
Tasimelteon has higher affinity for M2 subtype, thought to be more important for sleep: but is 30 times more expensive
Tasimelteon (Hetlioz)
Metabolism
CYP1A2 and CYP3A4
Where are orexin synthesizing neurons located?
Lateral and posterior hypothalamus
What are orexins?
Wake promoting peptides which bind to OX1 and OX to receptors (Gs) in the CNS
Describe the awake state
Limbic/SCN/Energy balance act on orexin neurons which activate wake-active neurons which inhibit Sleep-active neurons/preoptic area (POA).
POA would otherwise be inhibiting wake active and orexin neurons
Describe the sleep state
No Limbic/SCN/Energy balance to activate orexin neurons:
Pre optic area (POA) inhibits orexin neurons and wake-active neurons
Suvorexant (Belsomra)
MOA
OX1 and OX2 Receptor antagonist in hypothalamus: Sleep induction